货号:GS40661
Sirukumab is a human monoclonal antibody targeting interleukin-6 (IL-6), a pro-inflammatory cytokine. It binds to soluble IL-6 with high affinity, preventing its interaction with both soluble and membrane-bound IL-6 receptors. It was investigated for the treatment of rheumatoid arthritis (RA), but development was discontinued after regulatory reviews highlighted safety concerns, including increased risk of serious infections and mortality.
科技型中小企业
高新技术企业
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
冉凯凯